Retatrutide has emerged as a new medication in the fight against obesity. This groundbreaking drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating https://safahglh289789.eedblog.com/36396253/retatrutide-a-promising-new-treatment-for-obesity